What is the official ID of this bill?

The official print number for this legislation is HR 7512.

When did the legislative process begin?

The process officially started on 2024-03-01.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/118/bills/hr7512/BILLS-118hr7512ih.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Who is the primary sponsor?

The primary sponsor is Rep. Arrington, Jodey C. [R-TX-19].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-549, Part I.

Analysis and Potential Impact of HR 7512

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Improved Access to Medicare Drug Information

Q: What are the main provisions?

Key points include: By January 1, 2027, prescription drug plan sponsors under Medicare Part D must implement electronic real-time benefit tools. These tools will enable patients to quickly compare drug costs and find cheaper alternatives, potentially reducing their out-of-pocket medication expenses. The goal is to increase transparency and empower citizens to make better decisions regarding their treatment and personal finances.

This act aims to make it easier for citizens to access information about drug costs and alternatives within the Medicare program. By 2027, insurance companies will be required to provide online tools that allow for quick checking of prices and treatment options, potentially helping to save money and make informed health decisions.

Key points

By January 1, 2027, prescription drug plan sponsors under Medicare Part D must implement electronic real-time benefit tools.

These tools will enable patients to quickly compare drug costs and find cheaper alternatives, potentially reducing their out-of-pocket medication expenses.

The goal is to increase transparency and empower citizens to make better decisions regarding their treatment and personal finances.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

Real-Time Benefit Tool Implementation Act

Print number: HR 7512

Sponsor: Rep. Arrington, Jodey C. [R-TX-19]

Process start date: 2024-03-01

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-05-20

Source data: api.congress.gov

AI work logs for this document launch

Improved Access to Medicare Drug Information

Key Questions about Improved Access to Medicare Drug Information